Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 574 for “"Metformin"”.

  1. Obesity and metformin in pregnancy

    … trial designed to examine the efficacy of metformin, an insulin-sensitising agent, in obese pregnant women. The aim of the trial was to determine whether giving metformin to obese pregnant women from between 12 and 16 weeks’ gestation until birth, would improve maternal and fetal outcomes. …

    edinburgh Repository record for Obesity and metformin in pregnancy (opens in a new tab)

  2. Expanding the use of metformin: the pharmacokinetics and safety of metformin in contraindicated patient populations.

    Metformin is first-line therapy in the treatment of type 2 diabetes mellitus (T2DM). Contraindications due to a perceived increased risk of lactic acidosis include end-stage kidney disease (ESKD) and hepatic insufficiency. These patients are currently excluded from the additional benefits of …

    unsw Repository record for Expanding the use of metformin: the pharmacokinetics and safety of metformin in contraindicated patient populations. (opens in a new tab)

  3. Metformin: from antidiabetic to cancer therapeutic

    … have found that type 2 diabetics treated with metformin are at a lower risk for developing cancer. It was speculated that the lowered risk might be attributed metformin's indirect physiological effect of lowering blood insulin levels, which is the opposite of many other antidiabetic drugs. …

    bu Repository record for Metformin: from antidiabetic to cancer therapeutic (opens in a new tab)

  4. Mechanism of Metformin Action in Dermal Fibroblasts

    … insulin therapy include biguanide drugs such as metformin. Metformin downregulates gluconeogenesis, and reduces blood glucose levels by activating glucose transport via GLUT4 in muscle cells. Importantly metformin has been shown to decrease mitochondrial respiratory complex I activity in …

    utmb Repository record for Mechanism of Metformin Action in Dermal Fibroblasts (opens in a new tab)

  5. Metformin and Prostate Cancer among Diabetic Men

    … In the first paper, we tested the association of metformin use with prostate cancer incidence. In the second paper, we examined the association of metformin use with all-cause and prostate cancer specific mortality. The final paper explored the benefit of detailed pathology review to predict …

    toronto-retro Repository record for Metformin and Prostate Cancer among Diabetic Men (opens in a new tab)

  6. Effect of metformin on breast cancer metabolism

    … in the anti-cancer effects of the diabetes drug metformin as evidenced by the 50 clinical trials worldwide investigating the role of metformin in cancer treatment that are actively recruiting patients. Metformin’s potential anti-cancer effects were first brought to light following a series of …

    oxford Repository record for Effect of metformin on breast cancer metabolism (opens in a new tab)

  7. Antibacterial Properties Of The Diabetic Drug Metformin

    … or adjuncts to existing antimicrobial agents. Metformin, a widely used antidiabetic drug, has recently demonstrated antibacterial activity against various bacterial species. However, its mechanism of action and the bacterial response to metformin remain unclear and sometimes contradictory. This …

    east-anglia Download PDF for Antibacterial Properties Of The Diabetic Drug Metformin (opens in a new tab)

  8. Insulin Resistance and Metformin in Type 1 Diabetes

    … by adjunctive therapies in type 1 diabetes. Metformin is a simple oral medication traditionally used in type 2 diabetes. In type 2 diabetes, metformin is associated with reduced insulin resistance and CV mortality. The role of muscle and liver insulin resistance in determining CV risk, and …

    unsw Repository record for Insulin Resistance and Metformin in Type 1 Diabetes (opens in a new tab)

  9. Metformin as a potential therapy for malignant astrocytoma

    … medication as a possible alternative option. Metformin is from the biguanide family of drugs and is the most common medication used in the treatment of type 2 diabetes. Clinical studies have reported that, in type 2 diabetic patients, metformin might reduce cancer incidence and severity. …

    wlv Repository record for Metformin as a potential therapy for malignant astrocytoma (opens in a new tab) Download file for Metformin as a potential therapy for malignant astrocytoma (opens in a new tab)

  10. Metformin as a Treatment for Cocaine Use Disorder

    … that lowers the risk of relapse in CUD. Metformin, a Type 2 Diabetes treatment, has shown pre-clinical promise in reducing cocaine reinstatement after a period of withdrawal when administered intracranially in female and male rats. This thesis includes three studies that further examines …

    umn Repository record for Metformin as a Treatment for Cocaine Use Disorder (opens in a new tab)

  11. The effects of metformin on the vascular system

    … contraction and relaxation effects of metformin were measured using a Mulvany Halpern myograph. Mouse aortic ring sections were treated for 1 and 4 hours in vitro with metformin at 10-5M, and for 2, 4 and 8 weeks in vivo with metformin at 250mg/kg/day. The rings were contacted with …

    aston Download PDF for The effects of metformin on the vascular system (opens in a new tab)

  12. The Effects of Metformin on Pancreatic Cancer Metabolism

    Metformin (MET) is a widely used drug indicated for type-2 diabetes management. Interestingly, numerous epidemiological studies show that MET may confer protective benefits from overall cancer risk and cancer-related mortality. Various pre-clinical studies show that MET also exerts chemotherapeutic …

    arizona-thes Repository record for The Effects of Metformin on Pancreatic Cancer Metabolism (opens in a new tab)

  13. Metformin Arrests Growth and Induces Apoptosis of Neuroblastoma Cells

    … cytotoxic therapy with evidence of p53 mutation. Metformin, an oral hypoglycemic medication, is a relatively safe and cost effective drug with wide clinical applications, mainly for treatment of Type 2 diabetes. Recent studies have showed promising anticancer effect of metformin on various cancer …

    south-carolina Repository record for Metformin Arrests Growth and Induces Apoptosis of Neuroblastoma Cells (opens in a new tab)

  14. Therapeutic Modulation of Cancer Metabolism with Dichloroacetate and Metformin

    … reports demonstrate that the anti-diabetic drug metformin enhances the damaging oxidative stress associated with DCA treatment in cancer cells. We sought to elucidate the role of metformin’s reported activity as a mitochondrial complex I inhibitor in the enhancement of DCA cytotoxicity in the …

    usf Repository record for Therapeutic Modulation of Cancer Metabolism with Dichloroacetate and Metformin (opens in a new tab)

  15. The Effects of Metformin on Obesity-Induced Diabetic Retinas

    … glucose levels in type 2 diabetic patients, metformin is popularly prescribed as an oral drug in mono- and combination therapies. Metformin was used as a responsive and preventative drug on high-fat diet (HFD) induced obese mice that emulate type 2 diabetes. Body weight was monitored weekly …

    tamu Repository record for The Effects of Metformin on Obesity-Induced Diabetic Retinas (opens in a new tab)

  16. Metformin reguliert miR205/VEGF-A in Nierenzellkarzinomen in Abhängigkeit des VHL-Status – eine molekulare Begründung des klinischen Synergismus von Metformin und Angiogenese-Inhibitoren

    … veröffentlichte Berichte deuten an, dass eine Metformineinnahme mit einem positiven Outcome hinsichtlich klarzelligen Nierenzellkarzinomen (clear cell renal cell carcinoma, ccRCC) in Verbindung gebracht werden kann, wenn diese Patienten mit Sunitinib oder Axitinib behandelt werden. Daher wurde …

    wurz-thes Repository record for Metformin reguliert miR205/VEGF-A in Nierenzellkarzinomen in Abhängigkeit des VHL-Status – eine molekulare Begründung des klinischen Synergismus von Metformin und Angiogenese-Inhibitoren (opens in a new tab)

  17. Influence of Metformin in Obese Pediatric Patients with Comorbidities [poster]

    … there is limited research surrounding the use of metformin for treatment of pediatric obesity and concurrent health conditions. This systematic review examines the influence of metformin in pediatric obese patients with comorbid health conditions. A review of primary research was carried out in …

    texas-state Repository record for Influence of Metformin in Obese Pediatric Patients with Comorbidities [poster] (opens in a new tab)

  18. Influence of Metformin in Obese Pediatric Patients with Comorbidities [paper]

    … there is limited research surrounding the use of metformin for treatment of pediatric obesity and concurrent health conditions. This systematic review examines the influence of metformin in pediatric obese patients with comorbid health conditions. A review of primary research was carried out in …

    texas-state Repository record for Influence of Metformin in Obese Pediatric Patients with Comorbidities [paper] (opens in a new tab)

Page 1 of 29